heart failure Flashcards

1
Q

inability of the heart to meet the body’s metabolic needs. at rest or during stress, without exceeding physiologic left and right filling pressures s

A

heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common primary diagnosis on admissions within the medicare population

A

heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

total cost of heart failure in US

A

28.8 billion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cost of HF sustainable?

A

nope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

independent risk factors of HF

A
  1. HTN
  2. obesity
  3. diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

treatments for HF

A
  1. digoxin
  2. diuretics
  3. bed rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HF prognosis

A
  1. progressive disability

2. uniform mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

determinants of systolic performance

A

ejection fraction:

  1. myocardial mass and architecture
  2. contractility
  3. preload
  4. afterload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how to measure cardiac output

A

thermodilution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

goal of managing HF

A

achieve adequate cardiac output while minimizing wedge P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diastolic relaxation components (3)

A
  1. Myofibrillar dissociation
  2. Calcium removal from the cytoplasm against the concentration gradient
  3. Requires enzymatic action and energy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diastolic passive compliance components (2)

A
  1. A tissue property (stress-strain relationship) during passive myocardial stretch
  2. A ventricular property related to both myocardial stretch response and to constraining effect of contiguous structures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Systolic dysfunction:

  1. Etiology
  2. Pathology components
  3. Pathophysiology
A
  1. Chronic volumes overload, ischemia, infectious, substance abuse or genetic
  2. Dilated LV and hypertrophied LV and/or RV
  3. Decrease in contractility and decrease resting EF (LV remodeled with dilation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diastolic dysfunction; HHpEF; Metabolic CV dx.:

  1. Etiology
  2. Pathology
  3. Pathophysiology
A
  1. HTN, Diabetes, Obesity and advanced age
  2. Hypertrophy, fibrosis w/out dilatation
  3. NI resting EF (non-dilated LV) with decrease relaxation and decrease in compliance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Increased load structure HF:

  1. Etiology
  2. Pathology
  3. Pathophysiology
A
  1. Valvular, congenital, obstructive, systemic shunt
  2. Hypertrophy and/or dilatation
  3. Pressure and/or volume overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Increased load and demand HF:

  1. Etiology
  2. Pathology
  3. Pathophysiology
A
  1. Anemia and thyrotoxicosis
  2. Dilated and hypertrophied LV and RV
  3. Increased C.O. And increased O2 consumption or decreased O2 extraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Restrictive/ constrictive HF:

  1. Etiology
  2. Pathology
  3. Pathophysiology
A
  1. Infiltration, inflammatory and neoplasticism
  2. Infiltrated / thickened mayo/ pericardium
  3. Restricted LV and RV filling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Left Heart failure HF:

  1. Etiology
  2. Manifestations
A
  1. MI, cardiomyopathy, valvular congenital, HTN

2. Pulmonary congestion and low cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Right Heart failure:

  1. Etiology
  2. Manifestations
A
  1. Left heart failure, MI, cardiomyopathy, valvular, congenital, cardiomyopathy, lung disease and pulmonary emboli
  2. Peripheral edema, ascites, low cardiac output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Heart failure has a maladaptive adaptation

A

the heart will undergo hypertrophy to normalize wall stress and systolic function but it will lead to altered contractile proteins and calcium handling, apoptosis, fibrosis and failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

function of natriuretic peptides

A

vasodilate and promote sodium excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

high pulmonary venous pressure

A

left heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

high systemic venous pressure

A

right heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NY heart association class (4)

A
  1. no symptoms
  2. symptoms on mod-severe exertion
  3. symptoms on mild exertion
  4. symptoms at rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

ivabradine

A

heart rate lowering agent acting by inhibiting the If current in the sino-atrial node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Shift trial hypothesis

A

addition of ivabradine to recommended therapy would be beneficial in heart failure patients with elevated heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

neprilysin

A

inhibition leads to a potentiation of vasoactive peptides that counter maladaptive mechanisms in HF

28
Q

produces a positive inotropic effect through inhibition of the Na-K exchanger that results in higher intracellular sodium levels causing increased calcium transport via sodium-calcium exchange channel

A

digoxin

29
Q

the loss of what can worsen HF?

A

synchronous LV contraction

30
Q

most commonly used drug for suppression of ventricular arrhythmias in HF is

A

amiodarone

31
Q

indications for implantable cardioverter defibrillators

A

syncope or resuscitated cardiac arrest thought ti be due to a ventricular arrhythmia

32
Q

clinical assessment of hemodynamic status (2)

A
  1. thermodilution

2. swanz catheter

33
Q

thermodiultion can measure _____ but there are some pitfalls in inaccuracy such as with (2)

A

CO

  1. tricuspid regurg
  2. fluctuation in body temp
34
Q

Total uptake and release of a substance by an organ equals the blood flow to the organ and the arterio-venous concentration difference for that substance

A

Fick’s method

35
Q

Non-invasive general assessment of atrial, ventricular and valve structure and function

A

TTE

36
Q

Invasive and requires conscious sedation
Higher resolution imaging gives better assessment of valvular structure (e.g. infectious vegitations on valve from endocarditis)

A

TEE

37
Q

Color-flow doppler measures blood velocity (direction and speed) by either TTE or TEE
Does not measure pressure directly, but can make inferences about pressure by converting velocity to pressure:

A

echo

38
Q

Reflection of intravascular volume status
Estimated by pressure in the right atrium (“central venous pressure or CVP”) and/or left atrium (“pulmonary capillary wedge pressure”)

A

Preload: volume of blood in LV at end-diastole

39
Q

Reflection of the heart’s intrinsic ability to contract and generate force during systolic
Estimated generally by the Left Ventricular Ejection Fraction

A

Contractility: ability of myocardium to contract

40
Q

Left ventricular wall stress

Estimated by systemic vascular resistance (SVR) or mean arterial pressure

A

Afterload: resistance to ventricular contraction

41
Q

disease modifying therapies for HF

A
  1. catecholamine pathway
  2. RAAS pathway
  3. revascularization
42
Q

palliative therapies for HF

A
  1. diuretics

2. implantable defibrillator

43
Q

is a life-threatening medical condition of low tissue perfusion resulting in oxygen and nutrient deficit (ischemia/infarction) the impairs tissue function

A

Circulatory shock

44
Q

types of shock (4)

A
  1. hypovolemic
  2. cardiogenic
  3. septic
  4. obstructive
45
Q

causes:

  1. Hypovolemic
  2. Cardiogenic
  3. Septic
  4. Obstructive
A
  1. Hypovolemic
    GI bleeding, excessive diarrhea and dehydration

Cardiogenic
s/p large myocardial infarction, acute valvular disorder

Septic
Significant systemic infection

Obstructive
Pulmonary embolus

46
Q

primary problem:

hypovolemic

A

low preload

47
Q

primary problem:

cardiogenic

A

loss of contractility

48
Q

primary problem:

septic

A

non-specific vasodilation and dehydration

49
Q

primary problem:

obstructive

A

physical blockage preventing blood flow

50
Q

inotropic drugs used (3)

A
  1. Beta-adrenergic agonists
  2. phosphodiesterase inhibitors
  3. digitalis glycosides
51
Q

2 key components of diastolic function:

A
  1. relaxation

2. compliance

52
Q

is the process of myofibrillar dissociation, an active process requiring enzymatic action and energy to remove calcium from the cytoplasm against the concentration gradient.

A

relaxation

53
Q

is the passive property of the myocardium or of a cardiac chamber, describing (for an intact cardiac chamber) the change in volume for a given change in filling pressure, after relaxation is complete.

A

compliance

54
Q

. A low ejection fraction is generally accompanied by

A

ventricular dilatation.

55
Q

Systolic dysfunction is most often a consequence of

A

myocardial infarction (“ischemic cardiomyopathy”) or primary myocardial disease (“dilated cardiomyopathy”)

56
Q

Isolated, or primary, diastolic dysfunction occurs most commonly in the _____, as a consequence of long-standing hypertension and resulting left ventricular hypertrophy.

A

elderly

57
Q

Diastolic dysfunction may also occur as a consequence of___________, a family of genetic disorders linked to mutations of a variety of contractile proteins.

A

familial hypertrophic cardiomyopathy

58
Q

cor pulmonale a sign of

A

right heart failure

59
Q

long standing pressure-overload, as exemplified by hypertensive cardiomyopathy

A

diastolyc dysfunction

60
Q

ventricular dilatation, reduced ejection fraction, commonly referred to as

A

“systolic dysfunction”.

61
Q

hypertrophied myocyte manifests altered expression of

A

contractile proteins and of enzymes that regulate calcium movement,

62
Q

what does the adrenergic nervous system, RAAS pathway, vasopressin and endothelin do in HF?

A

these systems and substances tend to vasoconstrict; augment contractility; promote hypertrophy and interstitial fibrosis; and induce sodium and water retention.

63
Q

levels are elevated in heart failure.

A

B-type natriuretic peptide (BNP)

64
Q

effective means of preventing or reversing progressive left ventricular dilatation (ventricular remodeling) in heart failure.

A

carvedilol

65
Q

A typical regimen for such HF patients includes an

A

ACE inhibitor, beta blocker, digoxin, and diuretic.

66
Q

These agents are useful in the management of acute exacerbations of heart failure

A

vasodilators

67
Q

reduce pulmonary capillary (artery) wedge (PCW) pressure in patients with severe heart failure

A

dobutamine and milrinone